Yoshida M, Nakanishi T, Komatsu Y
Tohoku J Exp Med. 1986 Mar;148(3):327-31. doi: 10.1620/tjem.148.327.
A single blind cross over trial was conducted of thyrotropin-releasing hormone treatment in 7 patients with spinocerebellar degenerations. Patients received daily 2 mg of thyrotropin releasing hormone intramuscularly during the 2 week treatment period. Acute beneficial effect on stabilogram was demonstrated, but significant therapeutic efficacy in the chronic treatment failed to be demonstrated, though a trend of effectiveness was observed.
对7例脊髓小脑变性患者进行了促甲状腺激素释放激素治疗的单盲交叉试验。在为期2周的治疗期间，患者每天接受2毫克促甲状腺激素释放激素肌肉注射。结果显示对稳定图有急性有益作用，但在慢性治疗中未能证明有显著的治疗效果，不过观察到了一种有效的趋势。
